Yousef Mohamed Khalil, registration number 2231082, has been warned by the General Pharmaceutical Council (GPhC) over “regular issues with controlled drugs management” at the pharmacy where he worked as a responsible pharmacist.
On September 17, the GPhC’s investigating committee heard that Khalil was a “regular” responsible pharmacist and pharmacy manager at a Well Pharmacy branch between August 2024 and February 2025.
Read more: ‘Significant rise’: GPhC received almost 10,000 concerns this year
According to the determination document, audits at the pharmacy branch during this period identified the “non-destruction of out-of-date and returned medication, discrepancies in balances or no checks being carried out, keys to the safe unsecured and controlled drugs left unsecured in the pharmacy”.
One patient was also supplied morphine sulfate 5mg tablets “from an expired prescription on more than one occasion”, it added.
The GPhC said Khalil had breached its standards on working in partnership with others, demonstrating leadership and speaking up when one has concerns or things go wrong.
Read more: Pharmacist suspended over ‘dangerous’ overseas prescribing
But it recognised that he has “demonstrated some insight” and “reflected on his own practice to mitigate further the likelihood of a similar incident recurring”.
The regulator warned Khalil that “failing to properly discharge the duties of the responsible pharmacist, including in respect of the proper management of controlled drugs, can increase the risk of misuse or diversion which could lead to patient harm”.
“It also has the potential to undermine public trust and confidence in the profession,” it noted.
Read more: ‘Transactional’ pharmacist to return to practice after suspension
The committee said the warning will be published on the register and available for 12 months.
It added that repeated or similar conduct “will be likely to result in more serious regulatory intervention”.
Read the determination in full here.
